KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) EBT Margin: 2010-2025

Historic EBT Margin for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to 42.23%.

  • Exelixis' EBT Margin rose 1354.00% to 42.23% in Q4 2025 from the same period last year, while for Oct 2025 it was 38.16%, marking a year-over-year increase of 935.00%. This contributed to the annual value of 31.43% for FY2025, which is 1736.00% up from last year.
  • As of Q4 2025, Exelixis' EBT Margin stood at 42.23%, which was up 4.14% from 40.55% recorded in Q3 2025.
  • Exelixis' 5-year EBT Margin high stood at 45.96% for Q2 2024, and its period low was -67.49% during Q1 2021.
  • Over the past 3 years, Exelixis' median EBT Margin value was 28.68% (recorded in 2024), while the average stood at 26.78%.
  • Over the last 5 years, Exelixis' EBT Margin had its largest YoY gain of 3,267bps in 2021, and its largest YoY loss of 9,966bps in 2021.
  • Exelixis' EBT Margin (Quarterly) stood at 16.22% in 2021, then surged by 614bps to -7.41% in 2022, then surged by 2,890bps to 21.48% in 2023, then surged by 2,745bps to 28.68% in 2024, then skyrocketed by 1,354bps to 42.23% in 2025.
  • Its EBT Margin stands at 42.23% for Q4 2025, versus 40.55% for Q3 2025 and 37.03% for Q2 2025.